SCHEMBL21187291

SCHEMBL21187291

COc1ncnc2cc(N3CCOCC3)cc(O/C=N/C3CCC(NC(=O)OC(C)(C)C)CC3)c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.35
SUV39H2 Q9H5I1 3/20 0.34
MAP4K4 O95819 2/20 0.34
PRKDC P78527 2/20 0.34
CCRL2 O00421 1/20 0.34
KCNH2 Q12809 1/20 0.34
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
EGFR P00533 2/20 0.32
CFTR P13569 1/20 0.32
KDM4D Q6B0I6 1/20 0.32
PTK2 Q05397 1/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32
SKP2 Q13309 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21178579 0.86 RAF1 (0.40) BTKSUV39H2MAP4K4PRKDCCCRL2
SCHEMBL21187398 0.86 RAF1 (0.40) BTKSUV39H2MAP4K4PRKDCCCRL2
SCHEMBL21187339 0.76 MAP4K4 (0.38) BTKSUV39H2MAP4K4CCRL2DRD2
SCHEMBL21178350 0.74 JAK3 (0.41) BTKSUV39H2MAP4K4CCRL2DRD2
SCHEMBL21187338 0.74 JAK3 (0.41) BTKSUV39H2MAP4K4CCRL2DRD2
SCHEMBL30823290 0.73 PIK3CD (0.40) PRKDCKCNH2DRD2DRD3MEN1
SCHEMBL22651983 0.73 PIK3CD (0.40) PRKDCKCNH2DRD2DRD3MEN1
SCHEMBL28461575 0.73 PIK3CD (0.40) PRKDCKCNH2DRD2DRD3MEN1
SCHEMBL21279209 0.70 CACNB4 (0.39) BTKSUV39H2MAP4K4DRD2KDM4D
SCHEMBL16079597 0.70 CACNB4 (0.39) BTKSUV39H2MAP4K4DRD2KDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019143678-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-07-25 WO disclosed